Advertisement
Advertisement

Twenty-three U.S. troops suffered traumatic brain injury in Syria -US military

By:
Reuters
Published: Apr 15, 2023, 00:16 GMT+00:00

WASHINGTON (Reuters) - Twenty-three U.S. troops in Syria suffered traumatic brain injuries during two attacks in March by Iran-backed militants, the U.S. Central Command, which oversees U.S. forces in the Middle East, said on Friday.

Twenty-three U.S. troops suffered traumatic brain injury in Syria -US military

WASHINGTON (Reuters) – Twenty-three U.S. troops in Syria suffered traumatic brain injuries during two attacks in March by Iran-backed militants, the U.S. Central Command, which oversees U.S. forces in the Middle East, said on Friday.

“We have identified 11 additional cases of mild Traumatic Brain Injury from the March 23rd and 24th attacks in eastern Syria,” it said in a statement. “Twenty-three of those wounded and assessed as mTBI cases. Our medical teams continue to assess and evaluate our troops for indications of mTBI.”

Twenty-five U.S. troops were wounded as a result of the strikes and counter-strikes in Syria, which also killed an American contractor and injured another. The Pentagon estimated eight militants were killed during retaliatory U.S. air strikes against two Iran-linked facilities in Syria.

It is not the first time U.S. troops in the region have been diagnosed with brain injuries from attacks.

In 2020, more than 100 U.S. troops were diagnosed with traumatic brain injuries stemming from a missile attack by Iran against a base in Iraq.

(Reporting by Idrees Ali; writing by Jasper Ward; Editing by Leslie Adler)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Advertisement